Overall, 37 patients (22 %) had functioning tumors, including 29 insulinomas, 5 gastrinomas, 2 glucagonomas, and 1 adrenocorticotropic hormone (ACTH)-secreting tumor, whereas 134 patients (78 %) had nonfunctioning tumors. This evidence concerns the gene POMC and gastrin-producing neuroendocrine tumor.